​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ ​JOBS​​CALLS​​​​​​​​PR​ES​S​​​​​​RESTRICT​E​D AREA
Chi siamo

​Il Centro di Biomedicina è stato fondato nel 2009 in seguito alla volontà della Provincia autonoma di Bolzano di istituzionalizzare la cooperazione tra la ricerca e il sistema sanitario locale. Alla base di questa decisione politica, la convinzione che le sinergie tra ricerca medico-scientifica e pratica clinica siano fattori chiave per migliorare la sanità in Alto Adige e rendere più competitivo il sistema provinciale. Oggi il Centro di Biomedicina conta un team internazionale di ricercatori e collaboratori con background diversi che lavorano con passione per realizzare la missione e la visione del centro. Sono impegnati sia sul piano locale, lavorando a stretto contatto con il sistema sanitario, che a livello globale, prendendo parte a numerosi consorzi internazionali di ricerca.  

La storia

La ricerca medica approda in Eurac Research nel 2001. Seguendo la scia di un progetto sulla neuroepidemiologia (NEPT) avviato nel 1996 da una rete di neurologi e medici di base altoatesini, Eurac Research avvia il programma di ricerca GenNova. Si tratta di un importante progetto sulla salute della popolazione altoatesina. Nel 2004 GenNova diventa l'Istituto di Medicina Genetica di Eurac Research​, un istituto di ricerca che si concentra su studi di epidemiologia genetica sulle popolazioni isolate dell'Alto Adige. Successivamente l'Istituto di Medicina Genetica diventa il nucleo per lo sviluppo del Centro di Biomedicina. 


Research highlights​

 2012EURAC researchers contributed to a consortium of genetic research institutes led by Oxford University's Medical Science Division and helped to find 38 new genetic locii associated with glucose and insulin levels. The finding contributes to the identification of genetic mechanisms behind diseases such as type 2 diabetes. (Published in Nature Genetics)
 2012The Center for Biomedicine was front and centre in a new study on the genetic factors of chronic kidney disease published in March 2012's edition of 'PLoS Genetics'. EURAC's researchers were involved in the identification of six new regions of the human genome that affect kidney function.
 2011An international consortium including the Center for Biomedicine at EURAC recently conducted a study to identify genes responsible for the production of blood platelets. The work has contributed to the understanding of these biological mechanisms and the role they play in thrombotic and hemorrhagic diseases. 68 regions within the human genome that regulate the formation and structure of blood platelets have been identified. (Published in Nature)
 2011MICROS* data is used in a major international consortial effort that identifies many genetic variants and novel pathways that influence blood pressure and cardiovascular disease risk. (Published in Nature)
 2011EURAC researchers participate in studies that successfully identify novel genetic variants that correlate with the cardiac biomarkers CRP, and NT-pro-BN. (Published in Human Molecular Genetics and Circulation)
 2010EURAC researchers contribute to a study using functional animal model screens run by IMBA researchers that identify conserved regulators of heart function (published inCell) and to an additional consortia identifying novel genes related to heart function as revealed by the EKG trait, QRS interval. (Published in Nature Genetics)
 2010EURAC researchers contribute to several studies discovering hundreds of new genes underlying major heart disease risk factors—body mass indexblood cholesterol and lipid levelsglucose/diabetes, and kidney function. (Published in Nature and Nature Genetics)
 2009Ten genetic loci that modulate QT interval duration and may predispose to sudden cardiac death identified using data from the MICROS* alongside other studies. (Published in Nature Genetics)
 2008A re-evaluation of the nature of seeking informed consent in the genomics era. (Published in PLoS Medicine)
 2006Mapping of a novel locus for restless legs syndrome on chromosome 2q (RLS4). (Published in American Journal of Human Genetics)
 2005Identification of the largest pedigree of Parkin-mutation carriers identified to date, which is continuing to provide valuable research resources to study important molecular pathways in Lewy body Parkinson's. (Published in Annals of Neurology)

 

​​*MICROS (Micro-Isolate study in South Tyrol) is one of the building blocks of the GenNova program


CONTACT
Galvanistraße 31/Via Galvani 31
39100 BOZEN-BOLZANO
Tel. +39 0471 055 500
Fax. +39 0471 055 599
​​​​​​​​​​​​​​​​​​​​​​​​QUICK LINKS
RICONOSCIMENTI

 ​​​
  FOLLOW US​​


​​


  
CONTATTI

Viale Druso, 1 / Drususallee 1
39100 Bolzano / Bozen - Italy
Come raggiungerci​
Tel: +39 0471 055 055
Fax: +39 0471 055 099
Email: info@eurac.edu
Partita IVA: 01659400210
Priv​acy
Host of the Alpine Convention